MedTrace Logo

Dose Response Study of Dexmedetomidine in Orthopaedic Spine Surgery Patients

NCT02454881 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2020-09-22

No results posted yet for this study

Summary

To study the multimodal protocol combining adjunct dexmedetomidine with oxycodone in intravenous patient-controlled analgesia bolus dosing and effects in patients scheduled for posterolateral lumbar spine fusion with bilateral transpedicular screw instrumentation.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Dexmedetomidine

DRUG

Oxycodone

Sponsors & Collaborators

  • University of Helsinki

    collaborator OTHER

  • Turku University Hospital

    lead OTHER_GOV

Principal Investigators

  • Teijo I Saari, MD, PhD · Dept. Anaesthesiology and Intensive Care, University Of Turku

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2019-10-31
Completion
2020-03-01

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02454881 on ClinicalTrials.gov